Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herbert Brown Pharmaceutical & Research Laboratories (HBPRL) is an Indian pharmaceutical company specializing in the development, manufacturing, and export of generic formulations. Established in 2004 and headquartered in Mumbai, the company provides a wide array of therapeutic products across categories such as cardiology, diabetology, and anti-infectives. HBPRL operates GMP-compliant manufacturing facilities in Palghar and offers contract manufacturing and research services to global pharmaceutical partners. The company is dedicated to providing affordable, high-quality medicines and has a significant presence in international markets, particularly in emerging economies. Their product portfolio includes a variety of dosage forms such as tablets, capsules, and liquid orals, catering to both chronic and acute therapeutic segments. HBPRL emphasizes research and development to optimize drug delivery and ensure compliance with international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herbert Brown Pharmaceutical.